A 32-year-old woman is evaluated in the psychiatry clinic for ongoing management of major depressive disorder. She initially presented two years ago with a 3-month history of pervasive sadness, anhedonia, significant weight loss, and severe insomnia leading to functional impairment at work. Over the course of her illness, she has required progressive escalation of her treatment regimen due to inadequate responses. Arrange the following therapeutic interventions in the generally accepted chronological sequence that her physician would have followed, from initial diagnosis to the management of severe, treatment-resistant symptoms.
- 1Initiation of a selective serotonin reuptake inhibitor (SSRI)
- 2Switch to a serotonin-norepinephrine reuptake inhibitor (SNRI) monotherapy
- 3Augmentation with an atypical antipsychotic
- 4Referral for electroconvulsive therapy (ECT)
Answer
The correct sequence is: Initiation of an SSRI -> Switch to an SNRI monotherapy -> Augmentation with an atypical antipsychotic -> Referral for electroconvulsive therapy (ECT).
The standard stepped-care algorithm for major depressive disorder dictates starting with a single first-line agent, typically an SSRI. If the patient exhibits no response after an adequate trial, switching to a different monotherapy (such as an SNRI) is indicated. If there is persistent non-response or only a partial response after multiple sequential monotherapy trials, augmentation with an atypical antipsychotic, lithium, or a second antidepressant is appropriate. Finally, if the depression remains severely treatment-resistant despite these medication combinations, neuromodulation therapies such as electroconvulsive therapy (ECT) are considered.
Step-by-Step Solution
Key Concept
Stepped-care pharmacological escalation for major depressive disorder
Estimated Time:1m 30s